News

Published on 25 Dec 2024 on Insider Monkey · via Yahoo Finance

Will Corcept Therapeutics Incorporated (CORT) Make You Rich In 2025?


Article preview image

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we...

NASDAQ.FSSNX price evolution
NASDAQ.CORT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Corcept Submits Application for Another Cushing's Syndrome Drug

Corcept Therapeutics Incorporated CORT recently announced the submission of a new drug applicatio...

Zacks · via Yahoo Finance 31 Dec 2024

Will Corcept Therapeutics Incorporated (CORT) Make You Rich In 2025?

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we...

Insider Monkey · via Yahoo Finance 25 Dec 2024

CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study

Corcept Therapeutics Incorporated CORT announced data from the phase II DAZALS study evaluating i...

Zacks · via Yahoo Finance 12 Dec 2024

Beat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week....

Zacks · via Yahoo Finance 25 Nov 2024

Corcept Shares Rise More Than 60% in Three Months: Here's Why

Shares of Corcept Therapeutics Incorporated CORT have rallied 60.7% in the past three months agai...

Zacks · via Yahoo Finance 22 Nov 2024

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased...

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst...

Benzinga · via Yahoo Finance 30 Sep 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corc...

Insider Monkey via Yahoo Finance 2 May 2024

Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates

Corcept Therapeutics Incorporated CORT reported first-quarter 2024 earnings of 25 cents per share...

Zacks via Yahoo Finance 2 May 2024

20 companies screened for quality in a cheap part of the stock market

Small-cap and midcap U.S. stocks are trading relatively low to historical price-to-earnings...

Market Watch 23 Apr 2024

Corcept falls after phase 3 results on Cushing's candidate doesn't include some data

Corcept Therapeutics (CORT) reports positive phase 3 trial results for Cushing's syndrome candida...

Seeking Alpha 22 Apr 2024